Literature DB >> 23835724

Increased MerTK expression in circulating innate immune cells of patients with septic shock.

Caroline Guignant1, Fabienne Venet, Séverine Planel, Julie Demaret, Aurélie Gouel-Chéron, Christophe Nougier, Arnaud Friggeri, Bernard Allaouchiche, Alain Lepape, Guillaume Monneret.   

Abstract

PURPOSE: A new pathway of three protein tyrosine kinase receptors, namely, the TAM receptor family [Tyro-3, Axl and Mer tyrosine kinase (MerTK)], has recently been described to negatively control immune responses. The objective of this prospective, observational, clinical study was to investigate the expression patterns of TAM receptors in circulating white blood cells collected from patients with septic shock.
METHODS: The expression of TAM receptors was measured by flow cytometry in circulating leukocytes from patients with septic shock sampled on days (D) 1-2 (n = 47) and D3-4 (n = 37) after the onset of shock, severe trauma patients at D1-2 after trauma (n = 51) and healthy individuals (n = 23).
RESULTS: On D1-2 after injury, MerTK was overexpressed in monocytes and neutrophils collected from patients with septic shock in comparison with those collected from healthy volunteers and trauma patients. This phenomenon was also observed for mRNA. Conversely, the expression of Tyro-3 and Axl was higher in monocytes from trauma patients versus healthy volunteers or those in septic shock. MerTK expression between D1-2 and D3-4 remained elevated in patients suffering from septic shock who died or developed an intensive care unit-acquired infection, whereas it decreased in patients who recovered uneventfully. This in vivo observed expression pattern was reproduced ex vivo after the incubation of healthy volunteer cells with plasma from septic shock or trauma patients.
CONCLUSIONS: MerTK expression in circulating innate immune cells is increased in patients with septic shock in comparison with healthy volunteers and trauma patients. Persistent MerTK overexpression after septic shock is associated with adverse outcome. The role of this family of receptors in the pathophysiology of injury-induced immune dysfunctions deserves to be specifically investigated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23835724     DOI: 10.1007/s00134-013-3006-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  31 in total

1.  A comparative study of the protein C pathway in septic and nonseptic patients with organ failure.

Authors:  Delphine Borgel; Caroline Bornstain; Pieter H Reitsma; Nicolas Lerolle; Sophie Gandrille; Fouad Dali-Ali; Charles T Esmon; Jean-Yves Fagon; Martine Aiach; Jean-Luc Diehl
Journal:  Am J Respir Crit Care Med       Date:  2007-08-02       Impact factor: 21.405

Review 2.  Immunobiology of the TAM receptors.

Authors:  Greg Lemke; Carla V Rothlin
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

3.  Inhibiting Mer receptor tyrosine kinase suppresses STAT1, SOCS1/3, and NF-κB activation and enhances inflammatory responses in lipopolysaccharide-induced acute lung injury.

Authors:  Ye-Ji Lee; Ji-Young Han; Jiyeon Byun; Hyun-Jeong Park; Eun-Mi Park; Young Hae Chong; Min-Sun Cho; Jihee Lee Kang
Journal:  J Leukoc Biol       Date:  2012-03-16       Impact factor: 4.962

4.  Toll-like receptor-mediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages.

Authors:  Tingting Deng; Yue Zhang; Qiaoyuan Chen; Keqin Yan; Daishu Han
Journal:  Immunology       Date:  2012-01       Impact factor: 7.397

Review 5.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

Review 6.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Lancet Infect Dis       Date:  2013-03       Impact factor: 25.071

7.  Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction.

Authors:  Anne-Claire Lukaszewicz; Marion Grienay; Matthieu Resche-Rigon; Romain Pirracchio; Valérie Faivre; Bernadette Boval; Didier Payen
Journal:  Crit Care Med       Date:  2009-10       Impact factor: 7.598

8.  The sepsis seesaw: tilting toward immunosuppression.

Authors:  Richard S Hotchkiss; Craig M Coopersmith; Jonathan E McDunn; Thomas A Ferguson
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440

Review 9.  [Gas-6 and protein S: vitamin K-dependent factors and ligands for the TAM tyrosine kinase receptors family].

Authors:  Omar Benzakour; Aurore Gely; Romain Lara; Valérie Coronas
Journal:  Med Sci (Paris)       Date:  2007-10       Impact factor: 0.818

10.  Upregulation of Mer receptor tyrosine kinase signaling attenuated lipopolysaccharide-induced lung inflammation.

Authors:  Ji-Yeon Choi; Hyun-Jung Park; Ye-Ji Lee; Jiyeon Byun; Young-So Youn; Ji Ha Choi; So-Youn Woo; Jihee Lee Kang
Journal:  J Pharmacol Exp Ther       Date:  2012-11-29       Impact factor: 4.030

View more
  16 in total

1.  A Janus role for MerTK in the outcome of septic shock.

Authors:  Massimo Girardis; Andrea Cossarizza
Journal:  Intensive Care Med       Date:  2013-10-03       Impact factor: 17.440

Review 2.  Acute-on-chronic Liver Failure.

Authors:  Shiv Kumar Sarin; Ashok Choudhury
Journal:  Curr Gastroenterol Rep       Date:  2016-12

3.  The expression of inflammatory cytokines, TAM tyrosine kinase receptors and their ligands is upregulated in venous leg ulcer patients: a novel insight into chronic wound immunity.

Authors:  Kata Filkor; Tibor Németh; István Nagy; Éva Kondorosi; Edit Urbán; Lajos Kemény; Győző Szolnoky
Journal:  Int Wound J       Date:  2015-07-20       Impact factor: 3.315

4.  Elevated plasmatic level of soluble IL-7 receptor is associated with increased mortality in septic shock patients.

Authors:  Julie Demaret; Astrid Villars-Méchin; Alain Lepape; Jonathan Plassais; Hélène Vallin; Christophe Malcus; Françoise Poitevin-Later; Guillaume Monneret; Fabienne Venet
Journal:  Intensive Care Med       Date:  2014-06-25       Impact factor: 17.440

Review 5.  Acute-on-chronic liver failure: terminology, mechanisms and management.

Authors:  Shiv K Sarin; Ashok Choudhury
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-03       Impact factor: 46.802

Review 6.  Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure.

Authors:  Tao Zhang; Kewei Sun; Ya Wang; Lei Huang; Ren Lang; Wei Jiang
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-02       Impact factor: 2.586

7.  The Axl receptor tyrosine kinase is a discriminator of macrophage function in the inflamed lung.

Authors:  Toshifumi Fujimori; Aleksander M Grabiec; Manminder Kaur; Thomas J Bell; Naoya Fujino; Peter C Cook; Freya R Svedberg; Andrew S MacDonald; Rose A Maciewicz; Dave Singh; Tracy Hussell
Journal:  Mucosal Immunol       Date:  2015-01-21       Impact factor: 7.313

8.  Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy.

Authors:  Brendan A Hilliard; Gaetano Zizzo; Mehriban Ulas; Margaret K Linan; Jessica Schreiter; Philip L Cohen
Journal:  Arthritis Res Ther       Date:  2014-03-21       Impact factor: 5.156

9.  Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections.

Authors:  David Grimaldi; Lionel Le Bourhis; Bertrand Sauneuf; Agnès Dechartres; Christophe Rousseau; Fatah Ouaaz; Maud Milder; Delphine Louis; Jean-Daniel Chiche; Jean-Paul Mira; Olivier Lantz; Frédéric Pène
Journal:  Intensive Care Med       Date:  2013-12-10       Impact factor: 17.440

10.  Sepsis and the innate-like response.

Authors:  James J Douglas; Jennifer L Y Tsang; Keith R Walley
Journal:  Intensive Care Med       Date:  2013-12-10       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.